Co-Diagnostics, Inc. (CODX) DCF Valuation

Co-Diagnostics, Inc. (CODX) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Co-Diagnostics, Inc. (CODX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify Co-Diagnostics, Inc. (CODX) valuation with this customizable DCF Calculator! Featuring real Co-Diagnostics, Inc. (CODX) financials and adjustable forecast inputs, you can test scenarios and uncover Co-Diagnostics, Inc. (CODX) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .2 74.6 97.9 34.2 6.8 6.6 6.3 6.1 5.9 5.7
Revenue Growth, % 0 34579.9 31.3 -65.04 -80.09 -3.46 -3.46 -3.46 -3.46 -3.46
EBITDA -6.0 41.8 46.4 -10.3 -41.5 -1.7 -1.6 -1.6 -1.5 -1.4
EBITDA, % -2801.84 56.11 47.4 -30.13 -608.86 -25.32 -25.32 -25.32 -25.32 -25.32
Depreciation .1 .1 .3 1.3 1.2 .7 .7 .7 .6 .6
Depreciation, % 30.66 0.18596 0.34261 3.84 18.06 10.62 10.62 10.62 10.62 10.62
EBIT -6.1 41.7 46.1 -11.6 -42.7 -1.7 -1.7 -1.6 -1.6 -1.5
EBIT, % -2832.49 55.93 47.06 -33.96 -626.92 -26.2 -26.2 -26.2 -26.2 -26.2
Total Cash .9 47.3 89.9 81.3 58.5 6.0 5.8 5.6 5.4 5.2
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .1 12.1 20.9 5.4 .3
Account Receivables, % 61.12 16.28 21.37 15.78 4.86
Inventories .2 8.0 2.0 5.3 1.7 1.9 1.8 1.8 1.7 1.7
Inventories, % 91.72 10.72 2.05 15.52 24.44 28.89 28.89 28.89 28.89 28.89
Accounts Payable .0 .6 .6 1.0 1.5 .4 .4 .4 .3 .3
Accounts Payable, % 2.77 0.80254 0.62063 2.78 21.76 5.75 5.75 5.75 5.75 5.75
Capital Expenditure -.1 -.8 -.7 -1.4 -1.4 -1.0 -1.0 -1.0 -.9 -.9
Capital Expenditure, % -52.68 -1.04 -0.68392 -4.17 -20.04 -15.72 -15.72 -15.72 -15.72 -15.72
Tax Rate, % 7.29 7.29 7.29 7.29 7.29 7.29 7.29 7.29 7.29 7.29
EBITAT -6.0 41.6 37.0 -8.8 -39.6 -1.5 -1.5 -1.4 -1.4 -1.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -6.3 21.8 33.9 3.7 -30.5 -4.5 -1.7 -1.6 -1.6 -1.5
WACC, % 5.27 5.28 5.17 5.15 5.24 5.22 5.22 5.22 5.22 5.22
PV UFCF
SUM PV UFCF -9.7
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -2
Terminal Value -49
Present Terminal Value -38
Enterprise Value -47
Net Debt -12
Equity Value -35
Diluted Shares Outstanding, MM 29
Equity Value Per Share -1.20

What You Will Get

  • Real Co-Diagnostics Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Co-Diagnostics, Inc. (CODX).
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates to suit your analysis.
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Co-Diagnostics’ fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections specific to Co-Diagnostics, Inc. (CODX).
  • Time-Saving and Accurate: Skip building models from scratch while ensuring precision and flexibility in your financial assessments.

Key Features

  • Accurate Financial Data: Access reliable pre-loaded historical information and future forecasts for Co-Diagnostics, Inc. (CODX).
  • Adjustable Forecast Parameters: Modify highlighted fields such as WACC, growth rates, and profit margins.
  • Real-Time Calculations: Instant updates to DCF, Net Present Value (NPV), and cash flow assessments.
  • User-Friendly Dashboard: Clear charts and summaries to help visualize your valuation outcomes.
  • Suitable for All Levels: An intuitive layout designed for investors, CFOs, and consultants alike.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based CODX DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and more.
  3. Instant Calculations: The model automatically refreshes Co-Diagnostics’ intrinsic value.
  4. Test Scenarios: Experiment with different assumptions to assess potential valuation fluctuations.
  5. Analyze and Decide: Leverage the results to inform your investment or financial analysis.

Why Choose This Calculator for Co-Diagnostics, Inc. (CODX)?

  • All-in-One Solution: Offers DCF, WACC, and financial ratio analyses tailored for Co-Diagnostics, Inc. (CODX).
  • Flexible Inputs: Modify highlighted cells to explore different financial scenarios specific to Co-Diagnostics, Inc. (CODX).
  • In-Depth Analysis: Automatically computes the intrinsic value and Net Present Value for Co-Diagnostics, Inc. (CODX).
  • Rich Data Set: Historical and projected data provide reliable foundations for analysis related to Co-Diagnostics, Inc. (CODX).
  • Expert-Level Tool: Perfect for financial analysts, investors, and consultants focusing on Co-Diagnostics, Inc. (CODX).

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Co-Diagnostics, Inc. (CODX) stock.
  • Financial Analysts: Enhance valuation processes with ready-to-use financial models specific to Co-Diagnostics, Inc. (CODX).
  • Consultants: Provide clients with professional valuation insights on Co-Diagnostics, Inc. (CODX) quickly and accurately.
  • Business Owners: Gain insights into how companies like Co-Diagnostics, Inc. (CODX) are valued to inform your own business strategies.
  • Finance Students: Explore valuation techniques using real-world data and scenarios related to Co-Diagnostics, Inc. (CODX).

What the Template Contains

  • Preloaded CODX Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.